Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-097749
Filing Date
2025-07-23
Accepted
2025-07-23 09:39:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10505
  Complete submission text file 0000950170-25-097749.txt   12197
Mailing Address 9620 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Huang James (Filed by) CIK: 0001573160 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Subject) CIK: 0001962738 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94039 | Film No.: 251141878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)